Transdermal hormone replacement therapies
First Claim
Patent Images
1. A transdermal pharmaceutical formulation comprising progesterone and a solubilizing agent, wherein the solubilizing agent comprises an oil containing a C6-C12 fatty acid, wherein the progesterone is solubilized in the solubilizing agent and wherein the solubilized progesterone is present in a transdermal patch.
11 Assignments
0 Petitions
Accused Products
Abstract
Hormone replacement therapies are provided comprising solubilized progesterone alone and optionally with an estrogen, cyclic/sequential and continuous-combined dosing, and administered via transdermal HRT delivery systems.
-
Citations
20 Claims
- 1. A transdermal pharmaceutical formulation comprising progesterone and a solubilizing agent, wherein the solubilizing agent comprises an oil containing a C6-C12 fatty acid, wherein the progesterone is solubilized in the solubilizing agent and wherein the solubilized progesterone is present in a transdermal patch.
Specification